Groupama Asset Managment Sells 6,877 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Groupama Asset Managment cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 134,964 shares of the healthcare conglomerate's stock after selling 6,877 shares during the quarter. Groupama Asset Managment's holdings in UnitedHealth Group were worth $68,535,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. State Street Corp boosted its stake in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock valued at $26,626,387,000 after buying an additional 563,554 shares during the last quarter. Geode Capital Management LLC grew its holdings in UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after acquiring an additional 319,515 shares in the last quarter. Norges Bank acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $6,375,744,000. Franklin Resources Inc. increased its holdings in UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after buying an additional 861,854 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in UnitedHealth Group by 0.5% during the 4th quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate's stock worth $4,012,218,000 after buying an additional 36,394 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the company. Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, KeyCorp reaffirmed an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of "Buy" and a consensus price target of $629.32.

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH stock traded up $17.67 during mid-day trading on Thursday, reaching $540.87. The company's stock had a trading volume of 6,448,352 shares, compared to its average volume of 4,243,984. The company has a market cap of $494.74 billion, a P/E ratio of 34.89, a PEG ratio of 1.37 and a beta of 0.62. The firm's 50-day moving average is $509.15 and its two-hundred day moving average is $542.83. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same period in the prior year, the firm posted $5.83 EPS. UnitedHealth Group's quarterly revenue was up 6.8% compared to the same quarter last year. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.55%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.